Ischemic cardiomyopathy (ICM) is the most common cause of heart failure (HF) in the United
States and presents a significant burden on health care systems and patient quality of life. 1 …

Testing for cardiac ischemia, or for the obstructive coronary artery disease (CAD) that
causes cardiac ischemia, is common among hospitalized patients. Many testing options …

Background In patients with new-onset heart failure (HF), coronary artery disease (CAD)
testing remains underutilized. Whether widespread CAD testing in patients with new-onset …

BACKGROUND: Ischemic cardiomyopathy is the leading cause of heart failure (HF). Most
patients do not undergo coronary assessment after HF diagnosis. There are no randomized …

Background Guidelines recommend consideration of an ischemic evaluation (Class IIa-IIb)
in new-onset heart failure (HF), but it is not well-known how often this is performed and leads …

Heart failure (HF) is a chronic, progressive, and increasingly prevalent syndrome
characterized by stepwise declines in health status and residual lifespan. Despite significant …

Aims In heart failure (HF) with reduced left ventricular ejection fraction (HFrEF), the
prognosis appears better in non‐ischaemic than in ischaemic aetiology. Infrequent …

The effects of coronary revascularization in patients with left ventricle systolic dysfunction
(LVSD) are not well studied. The decision about revascularization and its timing remain …

Background: Though ischemic cardiomyopathy is the leading cause of heart failure (HF),
most patients do not undergo coronary assessment after heart failure diagnosis. In a safety …

Contemporary heart failure (HF) practice emphasizes timely and comprehensive evidence-
based medical therapies to minimize HF symptoms and hospitalizations, improve …